A study by Alvarez-Erviti et al. (2011) engineered the exosome with siRNA load to target the CNS cells and silence Alzheimer’s disease β secretase enzyme-1 (BACE1), which caused a decrease in Aβ1–42. Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.